1. Home
  2. ACR vs ELTX Comparison

ACR vs ELTX Comparison

Compare ACR & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$23.75

Market Cap

143.3M

Sector

Real Estate

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$8.16

Market Cap

158.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACR
ELTX
Founded
2005
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.3M
158.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACR
ELTX
Price
$23.75
$8.16
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$24.50
$13.00
AVG Volume (30 Days)
49.9K
111.5K
Earning Date
10-29-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
14.65
N/A
EPS
0.95
N/A
Revenue
$88,952,000.00
N/A
Revenue This Year
$4.05
N/A
Revenue Next Year
$0.38
N/A
P/E Ratio
$25.11
N/A
Revenue Growth
14.87
N/A
52 Week Low
$14.94
$4.60
52 Week High
$24.17
$12.62

Technical Indicators

Market Signals
Indicator
ACR
ELTX
Relative Strength Index (RSI) 70.16 44.30
Support Level $22.74 $7.90
Resistance Level $24.17 $9.00
Average True Range (ATR) 0.91 0.62
MACD 0.23 0.02
Stochastic Oscillator 94.16 36.32

Price Performance

Historical Comparison
ACR
ELTX

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: